ÌìÃÀÓ°Ôº

The American Society of Gene & Cell Therapy (ASGCT) Annual Meeting will bring together scientists, clinicians, industry leaders, and innovators to explore the latest breakthroughs shaping the field. The conference features a robust program of scientific sessions, keynote presentations, and networking opportunities designed to showcase cutting-edge research, emerging technologies, and clinical advancements. As the largest and most comprehensive meeting of its kind, ASGCT provides a unique platform for collaboration, knowledge sharing, and partnership across the industry, making it a must-attend event for those advancing next-generation therapies.

Date: May 11-15, 2026
Location: Thomas M. Menino Convention & Exhibition Center, Boston, Massachusetts
Booth: #1249

JOIN US!

Visit us at booth #1249 to discover how we accelerate AAV-based gene therapies and autologous, allogeneic, and iPSC-derived cell therapies—from development through commercialization. Speak with our experts to learn how our white-glove case management services deliver end-to-end supply chain management and orchestration of advanced therapies.

Complete the form to schedule a meeting with our experts!

SPEAKING ENGAGEMENTS

Session 1
Session chair: John Tomtishen, Global Head of Field Application Scientists and Strategic Alliances, ÌìÃÀÓ°Ôº
Date/Time: Monday, May 11, 1:00 – 5:25 PM
Title: Automation in CGT manufacturing: From production to QC (separate purchase required)

Session 2
Session chair: Carey Connelly, Senior Director Process Development, ÌìÃÀÓ°Ôº
Date/Time: Tuesday, May 12, 3:30-4:00 PM
Title: Design-Intensify-Characterize-Deliver: Empower your Journey to Patients with Industry’s CDMO Leader in Commercial AAV

Session 3
Session chair: John Tomtishen, Global Head of Field Application Scientists and Strategic Alliances, ÌìÃÀÓ°Ôº
Date/Time: Wednesday, May 13, 4:00-4:30 PM
Title: Fill Finish and Cryopreservation – the Final Mile of Success for Cell Therapies

ABOUT CATALENT

ÌìÃÀÓ°Ôº. is a leading global contract development and manufacturing organization (CDMO) championing the missions that help people live better and healthier lives. Every product that ÌìÃÀÓ°Ôº helps develop, manufacture and launch reflects its commitment to improve health outcomes around the world through its Patient First approach. ÌìÃÀÓ°Ôº provides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. ÌìÃÀÓ°Ôº tailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing. With thousands of scientists and technicians and the latest technology platforms at nearly 40 global sites, ÌìÃÀÓ°Ôº supplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.

 

Championing the missions that matterâ„¢